4 ms·
This also opens the door to eliminating stage 1/2/3 trials. Let the study leadership decide how to spread their risk budget, and to overlap them if they choos
by londons_explore 4y ago
This also opens the door to eliminating stage 1/2/3 trials. Let the study leadership decide how to spread their risk budget, and to overlap them if they choose to.
- refurb 4y agoThey already do this, especially for cancer. Phase 3 trials aren't always needed. Phase I/IIb are common.